OBM to debut on the emerging stock market on March 29th; negotiating authorization cooperation with three major products and clients

On the 20th, Original BioMedicals Co. Ltd. (OBM) submitted documents to the GreTai Securities Market for listing on the emerging stock market, with the expected debut of trading on March 29th, with a reference price (broker subscription price) of NT$20 per share. Currently, negotiations for authorization cooperation are underway with three major products.